ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Historical Holders from Q3 2014 to Q1 2025

Symbol
PRQR on Nasdaq
CUSIP
N71542109
Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
44.4M
Holdings value
$118M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
73
Number of buys
51
Number of sells
-14
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VAN HERK INVESTMENTS B.V. 10.9% $15.2M 11.5M Van Herk Investments B.V. Dec 31, 2024
Adage Capital Management, L.P. 9.3% $12.8M 9.6M Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 181K $241K $1.33 3
2024 Q4 44.4M $118M +$75.5M $2.65 73
2024 Q3 17.4M $31.7M +$265K $1.82 45
2024 Q2 17.3M $28.6M -$212K $1.66 47
2024 Q1 17.4M $39.8M -$2.23M $2.29 48
2023 Q4 18.4M $37M -$1.05K $1.98 46
2023 Q3 18.7M $24.3M -$3.6M $1.30 45
2023 Q2 21.1M $34.2M -$2.17M $1.62 50
2023 Q1 22.3M $47.5M +$11.1M $2.13 53
2022 Q4 16.7M $59.9M -$4.78M $3.70 44
2022 Q3 20.7M $15.5M -$757K $0.74 40
2022 Q2 21.7M $16.9M -$8.62M $0.78 46
2022 Q1 31.6M $28.6M -$92M $0.91 55
2021 Q4 45.4M $364M +$6.65M $8.01 70
2021 Q3 39.8M $333M +$12.2M $8.37 65
2021 Q2 38.5M $259M -$31.8M $6.74 62
2021 Q1 43.3M $286M +$121M $6.61 63
2020 Q4 25.2M $106M -$8.2M $4.20 44
2020 Q3 28M $134M -$5.87M $4.79 39
2020 Q2 29.1M $177M -$842K $6.08 42
2020 Q1 29.3M $161M -$7.2M $5.49 41
2019 Q4 30.2M $299M +$87.2M $9.91 51
2019 Q3 21.7M $125M -$19.2M $5.76 46
2019 Q2 23.6M $215M -$8.5M $9.10 51
2019 Q1 23.9M $332M +$9.45M $13.87 52
2018 Q4 23.1M $364M +$53.1M $15.78 56
2018 Q3 19.5M $376M +$166M $19.35 35
2018 Q2 11.1M $80.8M +$5.44M $7.30 24
2018 Q1 10.7M $32.9M -$2.76M $3.08 23
2017 Q4 11.5M $37.1M +$4.39M $3.22 25
2017 Q3 10.1M $48.9M +$5.21M $4.85 22
2017 Q2 9M $46.8M +$1.97M $5.20 17
2017 Q1 9.01M $45M +$634K $5.00 19
2016 Q4 8.89M $43.6M +$398K $4.90 21
2016 Q3 8.69M $58M -$2.94M $6.67 25
2016 Q2 9.15M $44.3M -$2.33M $4.84 26
2016 Q1 9.59M $46.8M -$10.7M $4.88 28
2015 Q4 11.2M $97.1M -$3.47M $8.68 32
2015 Q3 11.1M $162M +$4.01M $14.57 35
2015 Q2 10.8M $181M -$5.7M $16.67 35
2015 Q1 11M $241M +$65.7M $21.88 37
2014 Q4 8.02M $173M +$8.84M $21.67 35
2014 Q3 7.63M $130M +$130M $17.19 30